Special Features

Roche's phase III IMmotion151 study of Tecentriq & Avastin to treat advanced/metastatic RCC meets co-primary endpoint
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  
  ,  

Results Found: 1230

Go to Total Number of Pages: 62
PharmaBiz News
Pharmaceuticals exports grew 2.37 per cent in April 2025
View More →
PharmaBiz News
Pharmaceuticals exports grew 2.37 per cent in April 2025
View More →